terbutaline has been researched along with Paraproteinemias in 4 studies
Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.
Paraproteinemias: A group of related diseases characterized by an unbalanced or disproportionate proliferation of immunoglobulin-producing cells, usually from a single clone. These cells frequently secrete a structurally homogeneous immunoglobulin (M-component) and/or an abnormal immunoglobulin.
Excerpt | Relevance | Reference |
---|---|---|
"The regimen of terbutaline and aminophylline effectively prevents the attacks of hypotension and hemoconcentration that occur in systemic capillary leak syndrome." | 7.68 | Control of systemic capillary leak syndrome with aminophylline and terbutaline. ( Droder, RM; Greipp, PR; Kyle, RA, 1992) |
"The regimen of terbutaline and aminophylline effectively prevents the attacks of hypotension and hemoconcentration that occur in systemic capillary leak syndrome." | 3.68 | Control of systemic capillary leak syndrome with aminophylline and terbutaline. ( Droder, RM; Greipp, PR; Kyle, RA, 1992) |
"With the additional finding of a monoclonal gammopathy, the diagnosis of systemic capillary leak syndrome was made." | 2.41 | [Periodically leaking capillaries]. ( Keuter, M; Timmers, HJ; van der Meer, JW, 2000) |
"All patients had monoclonal gammopathy of immunoglobulin G type, with kappa light chains in 47 (68%)." | 1.46 | Intravenous Immunoglobulins Improve Survival in Monoclonal Gammopathy-Associated Systemic Capillary-Leak Syndrome. ( Abgueguen, P; Agard, C; Alric, L; Amoura, Z; Bibes, B; Blaison, G; Bosseray, A; Christides, C; Dossier, A; Gousseff, M; Graveleau, J; Hatron, PY; Lambert, M; Le Moal, S; Lega, JC; Levesque, H; Lhote, F; Lifermann, F; Lovey, PY; Lucchini-Lecomte, MJ; Malizia, G; Mauhin, W; Ninet, J; Pineton de Chambrun, M; Rivière, S; Ruivard, M; Saadoun, D; Soubrier, M; Tieulie, N; Viallard, JF, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pineton de Chambrun, M | 1 |
Gousseff, M | 1 |
Mauhin, W | 1 |
Lega, JC | 1 |
Lambert, M | 1 |
Rivière, S | 1 |
Dossier, A | 1 |
Ruivard, M | 1 |
Lhote, F | 1 |
Blaison, G | 1 |
Alric, L | 1 |
Agard, C | 1 |
Saadoun, D | 1 |
Graveleau, J | 1 |
Soubrier, M | 1 |
Lucchini-Lecomte, MJ | 1 |
Christides, C | 1 |
Bosseray, A | 1 |
Levesque, H | 1 |
Viallard, JF | 1 |
Tieulie, N | 1 |
Lovey, PY | 1 |
Le Moal, S | 1 |
Bibes, B | 1 |
Malizia, G | 1 |
Abgueguen, P | 1 |
Lifermann, F | 1 |
Ninet, J | 1 |
Hatron, PY | 1 |
Amoura, Z | 1 |
Timmers, HJ | 1 |
Keuter, M | 1 |
van der Meer, JW | 1 |
Droder, RM | 1 |
Kyle, RA | 1 |
Greipp, PR | 1 |
Doorenbos, CJ | 1 |
van Es, A | 1 |
Valentijn, RM | 1 |
van Es, LA | 1 |
1 review available for terbutaline and Paraproteinemias
Article | Year |
---|---|
[Periodically leaking capillaries].
Topics: Adrenergic beta-Agonists; Adult; Capillary Leak Syndrome; Diagnosis, Differential; Diagnostic Errors | 2000 |
3 other studies available for terbutaline and Paraproteinemias
Article | Year |
---|---|
Intravenous Immunoglobulins Improve Survival in Monoclonal Gammopathy-Associated Systemic Capillary-Leak Syndrome.
Topics: Capillary Leak Syndrome; Female; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Paraprotei | 2017 |
Control of systemic capillary leak syndrome with aminophylline and terbutaline.
Topics: Aged; Aminophylline; Blood Volume; Capillary Permeability; Drug Therapy, Combination; Female; Humans | 1992 |
Systemic capillary leak syndrome. Preventive treatment with terbutaline.
Topics: Adult; Capillary Permeability; Humans; Male; Paraproteinemias; Recurrence; Shock; Syndrome; Terbutal | 1988 |